Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- DODGE H. T., LORD J. D., SANDLER H. Cardiovascular effects of isoproterenol in normal subjects and subjects with congestive heart failure. Am Heart J. 1960 Jul;60:94–105. doi: 10.1016/0002-8703(60)90063-6. [DOI] [PubMed] [Google Scholar]
- Elliott W. C., Gorlin R. Isoproterenol in treatment of heart disease. Hemodynamic effects in circulatory failure. JAMA. 1966 Aug 1;197(5):315–320. [PubMed] [Google Scholar]
- Gunnar R. M., Loeb H. S., Pietras R. J., Tobin J. R., Jr Ineffectiveness of isoproterenol in shock due to acute myocardial infarction. JAMA. 1967 Dec 25;202(13):1124–1128. [PubMed] [Google Scholar]
- KRASNOW N., ROLETT E. L., YURCHAK P. M., HOOD W. B., Jr, GORLIN R. ISOPROTERENOL AND CARDIOVASCULAR PERFORMANCE. Am J Med. 1964 Oct;37:514–525. doi: 10.1016/0002-9343(64)90065-8. [DOI] [PubMed] [Google Scholar]
- Kleiger R., Lown B. Cardioversion and digitalis. II. Clinical studies. Circulation. 1966 Jun;33(6):878–887. doi: 10.1161/01.cir.33.6.878. [DOI] [PubMed] [Google Scholar]
- Morris J. J., Jr, Taft C. V., Whalen R. E., McIntosh H. D. Digitalis and experimental myocardial infarction. Am Heart J. 1969 Mar;77(3):342–355. doi: 10.1016/0002-8703(69)90190-2. [DOI] [PubMed] [Google Scholar]
- Murtagh J. G., Binnion P. F., Lal S., Hutchison K. J., Fletcher E. Haemodynamic effects of glucagon. Br Heart J. 1970 May;32(3):307–315. doi: 10.1136/hrt.32.3.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parmley W. W., Sonnenblick E. H. Glucagon: a new agent in cardiac therapy. Am J Cardiol. 1971 Mar;27(3):298–303. doi: 10.1016/0002-9149(71)90307-9. [DOI] [PubMed] [Google Scholar]
- Puri P. S., Bing R. J. Effects of glucagon on myocardial contractility and hemodynamics in acute experimental myocardial infarction. Basis for its possible use in cardiogenic shock. Am Heart J. 1969 Nov;78(5):660–668. doi: 10.1016/0002-8703(69)90518-3. [DOI] [PubMed] [Google Scholar]
- SANDLER H., DODGE H. T., MURDAUGH H. V., Jr Effects of isoproterenol on cardiac output and renal function in congestive heart failure. Am Heart J. 1961 Nov;62:643–651. doi: 10.1016/0002-8703(61)90372-6. [DOI] [PubMed] [Google Scholar]
- SELDINGER S. I. Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta radiol. 1953 May;39(5):368–376. doi: 10.3109/00016925309136722. [DOI] [PubMed] [Google Scholar]
- Selzer A. The use of digitalis in acute myocardial infarction. Prog Cardiovasc Dis. 1968 May;10(6):518–527. doi: 10.1016/0033-0620(68)90003-0. [DOI] [PubMed] [Google Scholar]
- Shillingford J., Thomas M. Hemodynamic effects of acute myocardial infarction in man. Prog Cardiovasc Dis. 1967 May;9(6):571–593. doi: 10.1016/s0033-0620(67)80010-0. [DOI] [PubMed] [Google Scholar]
- Smith H. J., Oriol A., Morch J., McGregor M. Hemodynamic studies in cardiogenic shock. Treatment with isoproterenol and metaraminol. Circulation. 1967 Jun;35(6):1084–1091. doi: 10.1161/01.cir.35.6.1084. [DOI] [PubMed] [Google Scholar]
- Swan H. J., Forrester J. S., Danzig R., Allen H. N. Power failure in acute myocardial infarction. Prog Cardiovasc Dis. 1970 May;12(6):568–600. doi: 10.1016/0033-0620(70)90022-8. [DOI] [PubMed] [Google Scholar]
- Talley R. C., Goldberg L. I., Johnson C. E., McNay J. L. A hemodynamic comparison of dopamine and isoproterenol in patients in shock. Circulation. 1969 Mar;39(3):361–378. doi: 10.1161/01.cir.39.3.361. [DOI] [PubMed] [Google Scholar]
- Weil M. H., Bradley E. C. Circulatory effects of vasoactive drugs in current use for treatment of shock. A reclassification based on experimental and clinical study of their selective arterial and venous effects. Bull N Y Acad Med. 1966 Nov;42(11):1023–1036. [PMC free article] [PubMed] [Google Scholar]